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Progesterone (P
4
) derivatives which are commonly used to block the cyclicity of domestic cats disturb the endocrine balance in
the endometrium. The aims of this study were (i) to examine whether lipopolysaccharide (LPS) is responsible for enhancement
of tumor necrosis factor-𝛼 (TNF𝛼) secretion by the feline endometrial epithelial and stromal cells in vitro, (ii) to know whether
immunolocalization of TNF𝛼/TNFR1 and TNFR2 differs in cats at estrus or diestrus, receiving medroxyprogesterone acetate
and suffering from pyometra, and (iii) to determine if TNF𝛼-challenged prostaglandin secretion is stopped by prostaglandin
synthases inhibitors. A total of 37 domestic adult cats in estrus or diestrus, receiving octane medroxyprogesterone or having
clinical symptoms of pyometra, were enrolled in this study. The results obtained showed a distinct increase in LPS-challenged
TNF𝛼 secretion in endometrial epithelial, but not stromal cells. TNF𝛼 augmented PG secretion was blocked by phospholipase
A
2
(PLA
2
) and cyclooxygeanase-2 (COX-2), but not by mitogen-activated protein kinase (MAPK) inhibitor. TNF𝛼/TNFR1 and
2 protein expressions were limited mostly to the surface and glandular epithelium. TNF𝛼/TNFRs protein was upregulated in the
inflammatory uterus and hence may be involved in development of pathologic changes in the endometrial glands in cats receiving
exogenous P
4
as a hormonal contraceptive.
1. Introduction
Cystic endometrial hyperplasia and pyometra complex is one
of the most common and important reproductive disorders
in cats [1, 2] and dogs [2, 3]. This syndrome is a sequel
to progesterone (P
4
) priming of the endometrium and is
mostly caused by an increasing endometrial infection with
vaginal bacteria [4]. An endocrine disturbance, particularly
with respect to P
4
imbalance, is prerequisite for development
of endometritis-pyometra complex (EPC) [4, 5]. A pyometra
is the most severe form of endometrial disease, accompanied
by accumulation of purulent fluid in the uterine lumen and
general toxemia. Microbial infection is necessary for the
development of pyometra; however, bacterial colonization
of the endometrium is always a secondary event to the
hormonal disturbances. Both female cats and dogs are sus-
ceptible to EPC, although in bitches this disorder is more
frequent because of prolonged exposure of the endometrium
to elevated P
4
levels during the nonpregnant luteal phase
[2]. For a long time, it was believed that ovulation in the
queen is induced by multiple copulations, and so, because
of the absence of mating, a single cat in a household
should be protected from progesterone stimulation of the
endometrium. However, in several studies describing EPC
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in cats, many of the affected animals were reported to
live in single-cat households but exhibited corpora lutea,
suggesting the occurrence of ovulation without mating in
this species [6–8]. Finally, the presence of noncopulatory
ovulation in domestic cats was confirmed by Lawler et al.
[9]. Even if a nonpregnant luteal phase appears in the cat,
it lasts only for 30–35 days [10, 11]. After that time, P
4
levels
drop to a basal value of around 1 ngmL−1. The shorter time
of endometrial exposure to elevated P
4
level may explain
the lower susceptibility of the feline endometrium to EPC
compared with dogs. However, P
4
derivatives, among them
medroxyprogesterone acetate or megestrol acetate, which
are commonly given to female cats for silencing sexual
behavior, cause hypertrophy of the endometrium, dilatation
and hypertrophy of the endometrial glands, or stimulation of
the endometrial glands to produce excessive mucus secretion
[6, 12]. Because of this, P
4
derivatives collectively facilitate the
development of EPC.
Although the endometrium is usually a sterile environ-
ment, microbial flora colonizing the lower urogenital tract of
clinically healthy queens may intrude into the uterine lumen,
resulting in the development of pyometra under favorable
conditions. The most common uterine infections in cats
are caused by the Gram-negative bacterium Escherichia coli
[8]; however, this species, accompanied by Proteus spp. or
Enterococcus faecalis, was also isolated from the vagina of
healthy cats [13]. Gram-positive bacteria were present to
a lesser extent and were overrepresented by Streptococcus
canis, Staphylococcus aureus, and Staphylococcus epidermidis
in queens without any clinical signs of EPC (for review
see Clemetson and Ward [14]). The mucosal membranes,
including the endometrium, are involved in host defense
against pathogens. The epithelial or stromal cells localized in
the mucosa use pattern-recognition receptors to detect the
presence of pathogens by recognizing pathogen-associated
molecular patterns (PAMP), such as microbial components,
including lipopolysaccharide (LPS) or lipoteichoic acid and
lipoproteins. Pathogen-associatedmolecular patterns are rec-
ognized by toll like receptors (TLRs) [15]. The localization
of TLRs in the endometrium of cats receiving medrox-
yprogesterone acetate or those suffering from pyometra or
cats in estrus or diestrus is now under study (Jursza and
Siemieniuch, unpublished, 2014). Activation of TLRs affects
the secretion of cytokines, among them tumor necrosis factor
𝛼 (TNF𝛼) and chemokines [16]. In the human endometrium,
TNF𝛼 is synthesized by immune-competent cells, such as
macrophages or monocytes, as well as by endometrial fibrob-
lasts [17] and glandular epithelial cells [18]. We showed
recently that TNF𝛼 is produced in the feline endometrium in
a cycle-dependent manner and is responsible for augmenta-
tion of prostaglandin secretion [19]. Otto and Rawlings [20]
observed that supernatants of peritoneal exudate cells from
cats produced vast amounts of TNF𝛼 when exposed to LPS.
However, data concerning the role of the feline endometrium
in innate responses during bacterial contamination remain
sparse.
In the present study, we hypothesized that LPS induces
TNF𝛼 secretion in the endometrial epithelial and stromal
cells of the domestic cat in vitro and TNF𝛼 affects
prostaglandin (PG) synthesis in endometrial cells. To address
this hypothesis, the following topics were examined: (i) LPS-
challenged secretion of TNF𝛼 by cultured epithelial or stro-
mal endometrial cells, (ii) spatial and temporal localization
of TNF𝛼 and its receptors in the feline endometrium, and
(iii) abolition of TNF𝛼-challenged prostaglandin secretion by
several PG synthase inhibitors.
2. Materials and Methods
2.1. Animals and Collection of Uteri. All procedures were
approved by the Local Animal Care and Use Committee
in Olsztyn, Poland (number 60/2010/DTN). A total of 37
mature, domestic shorthair cats were enrolled in this study.
The cumulative information provided by inspection of the
ovaries at ovariohysterectomy (OHE), circulating levels of P
4
,
and, when available, information from the owner were used
to stage the estrous cycle of each animal. No pharmacolog-
ical treatment was performed to provoke ovulation in the
animals. Queens were checked daily for behavioral signs of
estrus (treading of the hind feet, lordosis, and tail deflection).
The uteri were assigned to (1) estrus (E) group (𝑛 = 19);
(2) diestrus (D) group (𝑛 = 8); (3) hormonally treated with
medroxyprogesterone acetate (MPA, Depo-Promone, Pfizer
Animal Health, Louvain-la-Neuve, France) group (𝑛 = 7),
in which animals received an injection of 50mg MPA every
4 months and were ovariohysterectomized between four to
twelve months from the first injection; and (4) pyometric
(PYO) group (𝑛 = 3).
Tissues were washed immediately after surgery with
sterile saline to remove blood contamination, placed into
fresh sterile saline at 4∘C, and transported to the laboratory
within 1 h. Uterine horns were slit longitudinally and pieces
of endometrium were prepared and washed in a fresh saline.
One piece of an endometrium obtained from E (𝑛 = 4), D
(𝑛 = 8), MPA (𝑛 = 7), or PYO (𝑛 = 3) was formalin-
fixed and used for further immunohistochemical studies.The
rest of the endometrial pieces obtained from cats in estrus or
diestrus were used for cell isolation.
Experiment 1 (in vitro endometrial cell experiments)
2.1.1. Isolation and Culture of Feline Endometrial Cells. The
present protocol for isolation of endometrial epithelial or
stromal cells contains some important modifications of the
one previously described [21]. The major modifications were
the use of endometria from females in the estrus phase for
isolation of epithelial cells and the use of endometria from
diestrus females for isolation of stromal cells. These changes
provided better efficacy and lower cross-contamination of
the two types of cells. The uterine horns were separated and
cut longitudinally and small pieces of endometrium were
dissected from the myometrial layer with a scalpel blade and
washed once in sterile Hanks’ balanced salt solution (HBSS)
containing 20 𝜇gmL−1 of gentamicin (Invitrogen, San Diego,
CA, USA). The endometrial fragments were minced into
small pieces (approximately 1mm3) and digested by stirring
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for 60min in 50mL of sterile HBSS containing collage-
nase (2mgmL−1, Sigma Aldrich, St. Louis, MO), DNase
I (200𝜇gmL−1, Sigma Aldrich), and dispase (1.2 UmL−1,
Sigma Aldrich).
The mixture of cells together with cellular debris was
filtered through a pair of metal meshes (100𝜇m and then
80 𝜇m) to remove undissociated tissue fragments. Then,
the endometrial cell suspension was washed three times
by centrifugation 10min at 100×g, at 20∘C with Dulbecco’s
modified Eagle’smedium (DMEM/HamF-12 (D/F), 1 : 1 (v/v),
Sigma Aldrich) and suspended in 10mL fresh medium. The
cell concentration was counted using a hemocytometer. Cell
viability exceeded 90%as assessed by 0.04% (w/v) trypan blue
dye exclusion.
The final pellet of isolated endometrial cells was resus-
pended in D/F culture medium supplemented with 10%
(v/v) fetal calf serum (FCS, Sigma Aldrich) and 20 𝜇g/mL of
gentamicin (Invitrogen). The cells were seeded at a density
of 2 × 105 viable cells/mL in 75 cm2 culture flasks (Greiner
Bio-One,Monroe, NC) and cultured at 37.5∘C in a humidified
atmosphere of 5% CO
2
in air. The medium was changed
one hour after plating, by which time selective attachment
of stromal cells had occurred. In the case of luteal stage
endometria, the amount of stromal cells was enough for
plating into two culture flasks at the concentration stated
above. The rest of the culture medium, containing a small
amount of epithelial cells, was discarded. In the case of estrus
stage endometria, the medium was changed one hour after
plating; this medium, which contained the epithelial cells but
was free of already-attached stromal cells, was placed into a
new culture flask. The amount of epithelial cells was enough
for plating into one culture flask at the concentration stated
above. In case of sporadic contamination of the epithelial
cell cultures by stromal cells, 0.025% trypsin (Sigma Aldrich)
diluted in sterile Ca2+- and Mg2+-free phosphate-buffered
saline (PBS) was used for 3-4min at 20∘C to detach stromal
cells. After reaching confluence (3-4 days after the start of
the culture), the cells were rinsed twice with sterile PBS. In
order to collect stromal cells, the cell cultures were incubated
in 0.025% trypsin and 0.008% ethylene diamine tetraacetate
(EDTA) for 4-5min at 20∘C. To collect epithelial cells, the
cell cultures were incubated with 0.008% EDTA for 2min at
20∘C. The cell cultures were then rinsed in PBS to remove
contaminating stromal cells or fibroblasts.The cells were then
incubated with 0.025% trypsin for 8–10min at 20∘C and, at
the end of the incubation period, 25mL of D/F supplemented
with 10% FCSwas added to stop the enzymatic reaction. Both
types of cells were washed once by centrifugation (10min at
100×g). The pellets of both types of cells were resuspended
in 10mL of fresh D/F medium and the cell concentration
was counted using a hemocytometer. Cell viability exceeded
90% as assessed by 0.04% (w/v) trypan blue dye exclusion.
The cells were seeded at a density of 2 × 105 viable cells/mL
in a 48-well cluster dish (Greiner Bio-One, Monroe, NC)
and harvested as described for the primary cell cultures for
Experiments 1 and 2 or were seeded at a density of 2 × 104
per well in a MultiScreen sterile 96-well plate with a PVDF
membrane (Millipore) using fresh D/F without phenol red
supplemented with 0.1% BSA for Experiments 1.1, 1.2, 1.3, 1.4,
and 1.5.
Experiment 1.1 (immunofluorescence of endometrial cells).
Epithelial and stromal cells were identified using immunoflu-
orescent staining for specific markers of epithelial cells
(cytokeratin) or stromal cells (vimentin), as described pre-
viously [22]. Briefly, the epithelial- or stromal-derived cells
were seeded at 2 × 105 cells/mL in special slide flasks (Nunc,
Roskilde, Denmark) and cultured. After 48 h of culture, the
slides were washed three times in PBS, fixed in methanol
for 10min, and air-dried. Slides were then washed three
times in PBS. Triton X 100 0.01% in PBS was added to the
cell cultures for 10min at 20∘C. Then, the slides were again
washed three times in PBS and incubated for 12 h at 4∘C
with the primary antibody against either cytokeratin (mouse
monoclonal anti-human cytokeratin peptide 18; dilution
1 : 100, Sigma Aldrich) or vimentin (mouse monoclonal anti-
pig eye lens vimentin; dilution 1 : 200; Sigma Aldrich) in PBS.
Subsequently, the slides were washed three times in PBS and
then incubated with the second antibody (anti-mouse IgG
conjugated to insert types of fluorescent dyes used) for 1 h at
20∘C and protected against light. The controls were prepared
as described above in the absence of the primary antibody.
Images were captured using a digital camera (Leica, Solms,
Germany) and visualized under a fluorescence microscope
(Olympus, USA).
Experiment 1.2 (assessment of cell viability). Epithelial cells
isolated from cats in estrus (𝑛 = 4) were plated in 96-well
dishes at a density of 1 × 104 cells mL−1 and incubated for 4 h
at 37.5∘C with the same treatments as listed in Experiment
1.5. After culture, the cells were trypsinized in order to
count the cell numbers which was used to standardize
the results. The assay was based on the cleavage of the
yellow tetrazolium salt MTT [3-(4,5-dimethyl-2 thiazolyl)-
2,5-diphenyl-2H-tetrazolium/Br] to purple formazan crystals
by themitochondria ofmetabolic active cells.The absorbance
was measured at 450 nm using a microplate reader (model
450; Bio Rad, Hercules, CA, USA). Cell viability (%) was
calculated as follows: cell viability (%) = 100×(𝐴 test/𝐴control),
where 𝐴control is the mean 𝐴 of nontreated wells and 𝐴 test is
the mean𝐴 of all the experimental wells.The standardization
of results was based on DNA content [23].
Experiment 1.3 (LPS-challenged secretion of TNF𝛼). To deter-
mine TNF𝛼 production by endometrial cells, the equine
enzyme-linked immunosorbent assay (ELISpot) was used
(R&D Systems, Minneapolis, USA) following the manu-
facturer’s instructions. Stromal and epithelial cells isolated
from cats in estrus (𝑛 = 4) or diestrus (𝑛 = 4),
derived from passage 1, were seeded at a density of 2 ×
104 per well in a MultiScreen sterile 96-well plate with a
PVDF membrane (Millipore) using fresh DMEM without
phenol red supplemented with 0.1% BSA and antibiotics
and antimycotic solution. The density of cell seeding was
established in a preliminary experiment. Then, cells were
incubated with either vehicle alone, LPS purified from E.
coliO55:B5 (Sigma) (50 ng/mL), or LPS + TNF𝛼 (50 ngmL−1
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Figure 1: Epithelial and stromal cell culture.Homogeneity of the epithelial (a) and stromal (b) cell cultureswas assessed by immunofluorescent
staining for specific markers of epithelial cells (cytokeratin) and stromal cells (vimentin). Morphology of cultured feline endometrial cells:
primary cultures of epithelial (c) and stromal (d) cells under phase-contrast microscopy, on day 4 of culture.
+ 1 ngmL−1) for 24 h. The following controls were used:
positive control (TNF𝛼); negative control (unstimulated cells
at the same density as stimulated cells); background control
(culturemedium alone); and detection antibody control (PBS
substituted for the detection antibody). Spots were visualized
using the BCIP/NBT substrate detection system according
to the manufacturer’s instructions (Figure 1). The spots were
analyzed using an Eli. Scan scanner and software (A.EL.VIS
GmbH; Hannover; Germany).
Experiment 1.4 (optimization of culture conditions: dose-
dependent effects of TNF on 𝑃𝐺𝐹
2𝛼
and 𝑃𝐺𝐸
2
secretion). To
validate the cell culture model and to choose an optimal dose
of TNF𝛼 (among 0, 0.1, 1, and 10 ngmL−1) on prostaglandin
secretion, epithelial endometrial cells isolated from estrus
cats were used (𝑛 = 6). After 4 h incubation, conditioned
media from the control and treatment groups were collected
and stored at −20∘C until PGF
2𝛼
and PGE
2
analyses. Stan-
dardization of the results was based on DNA content [23].
Experiment 1.5 (effects of TNF, nimesulide, PD, anthranilic
acid, and arachidonic acid (AA) on 𝑃𝐺𝐹
2𝛼
and 𝑃𝐺𝐸
2
secretion
from cultured endometrial epithelial cells). To study modula-
tion of secretory function by the factors under investigation,
epithelial endometrial cells isolated from estrus cats (𝑛 =
6) were used because the epithelial cells, in contrast to
stromal cells, were responsible for distinctive TNF𝛼 secretion
followed by LPS stimulation. After the cells reached 80–90%
confluence, they were washed with M199 supplemented with
0.1% BSA and then incubated at 37.5∘C in fresh D/F medium
supplemented with 0.1% BSA and 20 𝜇gmL−1 of gentamicin
(Invitrogen, USA). After 30min stabilization, cells were
incubated for 4 h with one of the following treatments: (1)
control (without factors); (2) 1 ngmL−1 which corresponds
to 10−9M TNF𝛼 (Sigma Aldrich); (3) 10−6M AA (Sigma
Aldrich) as a positive control; (4) 10−8M nimesulide (NS-
398, Sigma Aldrich) which is a selective COX-2 inhibitor;
(5) 10−8M PD 98059 (Calbiochem, Darmstadt, Germany),
which is a selective, reversible, and cell-permeable inhibitor
of MAP kinase; (6) 10−8M N-(p-amylcinnanoyl)anthranilic
acid (ACA 104550) (Calbiochem), which is a cell-permeable
inhibitor of phospholipase A2. After 30min preincubation at
37.5∘C, TNF𝛼 was added at 1 ng mL−1 to the wells containing
factors (4), (5), and (6). After 4 h incubation at 37.5∘C,
conditioned media from the negative or positive control and
treatment groups were collected and stored at −20∘C until
PGF
2𝛼
and PGE
2
analyses. Standardization of the results was
based on DNA content [23].
Experiment 2 (spatial localization of TNF𝛼/TNFRs protein in
the feline endometrium). Formalin-fixed, paraffin-embedded
tissues were cut with a microtome (2-3𝜇m) and mounted
on SuperFrost Plusmicroscope slides (Menzel-Gla¨ser, Braun-
schweig, Germany). The experimental protocol was as previ-
ously described for feline ovaries and placenta [24]. Briefly,
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slides were deparaffinized and rehydrated in a graded ethanol
series and then incubated in citrate buffer (10 nM, pH 6.0)
for 15min under microwave irradiation at 560W for antigen
retrieval. Then, sections were incubated in 0.3% H
2
O
2
in
methanol for 30min to quench endogenous peroxidase and
thenwashed in IHC-buffer/0.3%TritonXpH7.2–7.4 (0.8mM
Na
2
HPO
4
, 1.47mM KH
2
PO
4
, 2.68mM KCl, and 1.37mM
NaCl). Blocking of nonspecific binding sites was performed
with 10% goat serum.The following primary antibodies were
used: TNF𝛼 (rabbit polyclonal to TNF𝛼; dilution 1 : 1500,
Abcam, Cambridge, MA, USA), TNFR1 antibody (rabbit
polyclonal to TNF Receptor I; dilution 1 : 1500, Abcam),
and TNFR2 (rabbit polyclonal to TNF Receptor II; dilution
1 : 25, Abcam). An isotype control was done to avoid false
positive results. The endometrial sections were incubated
with serial dilutions of preimmunized rabbit serum (Vector
Laboratories, Burlingame, USA), starting at 1 : 25. No positive
staining was observed at a 1 : 25 dilution of preimmunized
rabbit serum.
Sections were incubated overnight at 4∘C. After washing
with IHC-buffer, slides were incubated for 30min at 20∘C
with either biotinylated anti-rabbit IgG (secondary antibody;
dilution 1 : 100) (Vector Laboratories). For enhancing signals,
sections were incubated with the avidin-biotin-peroxidase
complex (VectastainABCkit, Vector Laboratories) for 30min
at 20∘C. After washing with IHC buffer, sections were
allowed to react with the substrate diaminobenzidine (DAB;
DakoCytomation, Glostrup, Denmark) according to the
manufacturer’s instructions. Slides were counterstained with
hematoxylin, rinsed under running tap water for 5min,
dehydrated in a graded ethanol series, and mounted in
mounting medium DPX (Panreac Quimica Sau, Barcelona,
Spain).
2.2. Immunohistochemical Scoring. A blind assessment of
immunolabeling intensity was performed with a Leica
(Solms, Germany)microscope. Immunoreactivity was scored
taking into account the staining intensity and distribution
of specific staining. Ten sight fields were inspected from
each slide. Positive signals were indicated as a dark brown
to brownish color. The TNF𝛼, TNFR1, and TNFR2 immu-
noexpressions were examined independently at the surface
epithelium, epithelial glands, and endometrial stroma. The
immunolabeling intensity was scored as negative (0), weak
(1), moderate (2), or strong (3).
2.3. Hormone Determinations. For PGF
2𝛼
and PGE
2
mea-
surements, the commercial PGF
2𝛼
high sensitivity EIA kit
and the PGE
2
high sensitivity EIA kit (both from ENZO Life
Sciences Inc., Farmingdale, NY, USA) were used and run
according to the manufacturer’s instructions.
The sensitivity of the PGF
2𝛼
assay was 0.98 pg/mL. The
cross-reactivity for various PGs and their metabolites was
as follows: PGF
2𝛼
: 100%, PGF
1𝛼
: 11.82%, PGD
2
: 3.62%, 6-
keto-PGF
1𝛼
: 1.38%, PGI
2
: 1.25%, and PGE
2
: 0.77%. The
inter- and intra-assay variation coefficients were 10.8% and
8.6%, respectively. The sensitivity of the PGE
2
assay was
8.26 pg/mL. The cross-reactivity for various prostaglandins
and theirmetabolites was as follows: PGE
2
: 100%, PGE
1
: 70%,
PGE
3
: 16.3%, PGF
1𝛼
: 1.4%, PGF
2𝛼
: 0.7%, and 6-keto-PGF
1𝛼
:
0.6%. The inter- and intra-assay variation coefficients were
12.2% and 6.9%, respectively.
2.4. Statistics. Data concerning concentrations of PGE
2
or
PGF
2𝛼
in conditioned media, epithelial cell viability, and
results obtained with ELISpot were analyzed by one-way
analysis of variance (ANOVA) and followed by the Newman-
Keuls multiple comparison test among means (GraphPad
PRISM, version 6.0; GraphPad Software Inc., San Diego,
CA, USA). Prostaglandin E
2
or PGF
2𝛼
concentrations in the
incubation media are shown as a mean ± SEM of values
obtained in all experiments. Significance was defined as a 𝑃
value of <0.05.
3. Results
3.1. Cell Culture Characterization. Cultured cells presented
two distinct characteristic morphologies: (1) cuboid or cylin-
drical shape with a distinct round nucleus (Figure 1(c)) and
(2) spindle-shaped or elongated with a slightly visible nucleus
(Figure 1(d)). Staining with cytokeratin or vimentin allowed
both cell types to be distinguished. Cuboid-shaped cells
stained with cytokeratin were classified as epithelial cells
(Figure 1(a)), whilst cells stained positively with mesenchy-
mal cells marker vimentin were classified as stromal cells
(Figure 1(b)).
3.2. Assessment of Cell Viability. There were no statistically
important changes in cell viability in epithelial cell cultures
from cats in estrus (𝑃 > 0.05) (data not shown).
3.3. Quantification of LPS-Challenged TNF𝛼 Secretion.
ELISpot showed that stromal cells produced a small
amount of TNF𝛼 after treatment with LPS (50 ngmL−1) and
LPS together with TNF𝛼 (50 ngmL−1 plus 1 ngmL−1)
(Figure 2(a)). In contrast to stromal cells, epithelial
cells secreted distinctly greater amounts of this cytokine
(𝑃 < 0.001) (Figure 2(b)). Epithelial cells produced 10.57- or
11.18-fold more spots when stimulated with LPS or LPS plus
TNF𝛼, respectively, than the control. Comparing the TNF𝛼
secretion profile in epithelial versus stromal cells, the former
secreted 19.07-fold more TNF𝛼 after challenging with LPS
and 37.5-fold more TNF𝛼 after challenging with LPS plus
TNF𝛼 than stromal cells.
3.4. Quantification of Prostaglandins in Culture Media. In
Experiment 1.4, the accumulated PGF
2𝛼
and PGE
2
concen-
trations in conditionedmedia collected from the endometrial
epithelial cell cultures increased at 4 h after TNF𝛼 treatment
at 0.1 (𝑃 < 0.001), 1 (𝑃 < 0.0001 or 𝑃 < 0.01 for PGF
2𝛼
and
PGE
2
, resp.), or 10 ng/mL (𝑃 < 0.0001 or 𝑃 < 0.01, resp.)
(Figures 3(a) and 3(b), resp.). Arachidonic acid increased
both types of PGs secretion in epithelial cells compared with
controls (𝑃 < 0.0001).
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Figure 2: Number of spots after incubation of epithelial cells (a) or stromal cells (b) with LPS at 50 ngmL−1 or LPS plus TNF𝛼 (at 50 ngmL−1
and 1 ngmL−1, resp.). Asterisks indicate statistical differences between numbers of spots depending on the treatment (∗∗∗𝑃 < 0.001).
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Figure 3: Dose-dependent effect of TNF𝛼 on PGF
2𝛼
(a) and PGE
2
(b) secretion/concentrations as determined by immunoassay in
endometrial epithelial cells (surface and glandular epithelium). Asterisks indicate statistical differences between prostaglandin (PG) levels
depending on the treatment (∗∗𝑃 < 0.01, ∗∗∗𝑃 < 0.001, and ∗∗∗∗𝑃 < 0.0001).
In Experiment 1.5, PG production by feline epithelial
endometrial cells was examined. Prostaglandin F
2𝛼
produc-
tion was increased after stimulation with TNF𝛼 and AA
(𝑃 < 0.001 and 𝑃 < 0.0001, resp.) and decreased after
stimulation with NS and NS/TNF𝛼 (𝑃 < 0.001), with
ACA (𝑃 < 0.01), and with ACA/TNF𝛼 (𝑃 < 0.05). An
inhibitor of MAP kinase, PD, alone or together with TNF𝛼
did not affect PGF
2𝛼
secretion in endometrial epithelial cells
(Figure 4(a)).
Prostaglandin E
2
production increased after stimulation
with TNF𝛼 and AA or after simultaneous treatment with PD
and TNF𝛼 (𝑃 < 0.0001). Prostaglandin E
2
concentration
decreased after stimulation with NS and NS together with
TNF𝛼 (𝑃 < 0.0001 and𝑃 < 0.001, resp.) and after stimulation
with ACA and ACA together with TNF𝛼 (𝑃 < 0.05 and
𝑃 < 0.01, resp.). An inhibitor of MAP kinase, PD, alone had
no effect on PGE
2
secretion (Figure 4(b)).
3.5. Immunolocalization of TNF𝛼/TNFRs Protein in
Feline Endometrium
3.5.1. Immunolocalization of TNF𝛼. Very strong signals were
observed in the surface and glandular epithelium but very
weak signals were seen in endometrial stroma in cats
from group E (Figure 5(a)). No or only weak signals were
observed in both epithelia and stroma in cats from group D
(Figure 5(b)). In uteri from cats receiving MPA, no or only
weak signals were observed in surface epithelium, weak to
moderate signals were seen mainly in deep endometrial
glands, and weak to moderate staining was observed in
endometrial stroma (Figure 5(c)). In inflamed uteri, strong
signals were observed in endometrial glands, whereas in the
surface epithelium the staining was weak to moderate. In the
endometrial stroma in pyometric cats, there were no or only
weak signals (Figure 5(d)).
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Figure 4: The content of PGF
2𝛼
or PGE
2
after different treatments as determined by immunoassays. Asterisks indicate statistical differences
between prostaglandin levels depending on the treatment (∗𝑃 < 0.05, ∗∗𝑃 < 0.01, ∗∗∗𝑃 < 0.001, and ∗∗∗∗𝑃 < 0.0001).
3.5.2. Immunolocalization of TNFR1. Weak intensity scores
were observed in the endometrial glands from group E or
group D cats (Figures 6(a) and 6(b), resp.), whereas in the
surface epithelium, staining was weak to moderate. The IHC
analysis revealed abundant positive signals in surface and
glandular epithelia from inflamed uteri (Figure 6(d)) and
distinct diversification of staining in the surface epithelium
of cats receiving MPA (Figure 6(c)). In that group, TNFR1
protein expression was weak to moderate in the endometrial
glands.No or onlyweak signals were observed in endometrial
stroma in all experimental groups.
3.5.3. Immunolocalization of TNFR2. Moderate to strongly
positive signals were localized in endometrial glands in
all groups (Figures 7(a), 7(b), 7(c), and 7(d)). Similarly,
moderate to strongly positive signalswere observed in surface
epithelium in all groups (Figures 7(a), 7(b), and 7(d)) with
the exception of MPA-treated queens (Figure 7(c)), in which
the staining levels were identified as none, weak, ormoderate.
No or only weak signals were observed for stromal TNFR2
protein expression in almost all tissue sections examined.
The negative (isotype) control showed no staining
(Figure 8). The immunohistochemical scoring results are
shown in Figure 9.
4. Discussion
In the present study, the separately cultured epithelial or
stromal cells secreted TNF𝛼 following LPS stimulation. This
observation stands in contrast to data obtained in bovine
endometrial cells, in which there was no detectable level of
TNF𝛼 after LPS challenge [25]. Similarly, in supernatants
from isolated murine epithelial or endometrial stromal cells
stimulated with various LPS, including LPS purified from E.
coliO55:B5 as in the present study, TNF𝛼 concentrationswere
low [26].These discrepanciesmay be due to species variations
or to the use of different methods for TNF𝛼 detection. In the
present study ELISpot was used instead of ELISA. ELISpot
immunoassays are designed for the detection and enumer-
ation of single cells secreting cytokines or other antigens.
These assays are highly sensitive and allow identification of
the secreting cells even when frequencies of these cells fall
below 1 in 100,000 [27]. The authors of previous studies on
bovine [25] and murine [26] endometrium concluded that
the neighbouring cells, like macrophages, are more likely
responsible than epithelial or stromal cells for LPS-challenged
TNF𝛼 production. An increase in TNF𝛼 production followed
by elevated PG secretion undoubtedlymay have an important
role in innate resistance of the endometrium to infection.
Interestingly, in the present study the number of TNF𝛼 spots
observed after LPS stimulation was distinctly higher in the
endometrial epithelial cells than in stromal cells. Indeed, the
epithelial cells regulate defensive strategies by orchestrating
innate immune responses [28].
In our previous study, we showed that isolated fragments
of feline uteri produce PGs after supplementation of the
culture media with TNF𝛼 [19]; similar results were shown
with endometrium of the cow [29], pig [30], horse [31],
and human [32]. Prostaglandins are synthesized from AA
by an enzymatic cascade and regulate a variety of processes
in reproduction and immune function [33]. The primary
enzyme responsible for inflammation-induced enzymatic
liberation of AA from membrane phospholipids is PLA
2
.
Consequently, inhibition of PLA
2
should diminish PG syn-
thesis. Previous studies showed that TNF𝛼/TNFR1 complex
activates PLA
2
[34] and experiments with ACA abrogated
TNF𝛼-challenged PG synthesis in the bovine endometrial
stroma [35]. In contrast to the earlier study [35], we clearly
demonstrated that TNF𝛼 enhanced PG secretion in feline
epithelial, not stromal cells. However, in accordance with the
report by Skarzynski et al. [35], we noticed an inhibiting
effect of ACA on TNF𝛼-challenged PG synthesis in feline
epithelium. In addition, a selective COX-2 inhibitor, NS,
completely abolished TNF𝛼-induced as well as basal PG
synthesis. The latter effect stands in contrast to earlier
results, in which COX-2 selective inhibitors, among themNS,
minimally affected basal PGE
2
secretion, although they were
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Figure 5: TNF𝛼 protein localization in endometria. Immunohistochemical (IHC) localization of TNF𝛼 in the endometria of cats collected
at (a) estrus phase (E; 𝑛 = 7) and (b) diestrus phase (D, 𝑛 = 8) from (c) cats that had been treated with a P
4
derivative analog,
medroxyprogesterone acetate (MPA, 𝑛 = 5; (d) cats presenting the clinical symptoms of pyometra (PYO, 𝑛 = 3). (a) In females at estrus, strong
TNF𝛼 signals are localized in glandular and surface epithelium; (b) in females at diestrus, some weak signals are localized in endometrial
stroma; (c) in MPA females, TNF𝛼 expression is localized mostly in deep glands and weaker signals are present in surface epithelium; (d) in
PYO females, signals are mostly localized in both the surface and the glandular epithelium. Surface epithelium: white arrowheads; glandular
epithelium: white arrows; endometrial stroma: black arrows.
extremely effective in abolishing TNF𝛼-stimulated PGE
2
synthesis [36]. The present study confirmed that PLA
2
and
COX-2 are involved in TNF𝛼-challenged PGs secretion in
cat endometrial cells, since the enhancing effect of TNF𝛼 on
PGs synthesis was abrogated by PLA
2
or COX-2 inhibitors.
Binding of TNF𝛼 with its receptor has been demonstrated
to activate several signaling pathways, including MAPK [37].
Furthermore, an activation of MAPK is implicated as a
signaling pathway for COX-2 gene transcription and protein
expression, that is, in vascular smooth muscle cells [38].
Consequently, we expected that administration of PD 98059
should abolish TNF𝛼-challenged PG secretion. Surprisingly,
the enhancing effect of TNF𝛼 on PGE
2
was not blocked
after incubation of epithelial cells with MAPK inhibitor.
In contrast, TNF𝛼 did not elevate PGF
2𝛼
secretion, when
administered together with PD. In the study by Sakumoto
et al. [39], MAPK inhibitor abolished TNF𝛼-enhanced PG
synthesis in bovine endometrium.
Tumor necrosis factor 𝛼 acts through two distinct recep-
tors, TNFR1 andTNFR2, althoughTNFR1 initiates themajor-
ity of the biological activities of TNF𝛼. Activation of TNFR1
triggers an intracellular cascade that results in the initiation
of twomajor transcription factors, nuclear factor 𝜅B (NF-𝜅B)
and c-Jun. These transcription factors are responsible for
the inducible expression of genes important for various
biological processes, including immune and inflammatory
responses [37]. In the present study, TNF𝛼/TNFR1 and 2were
shown to be differentially expressed depending on the uterine
conditions. In cats in the luteal phase, TNF𝛼 immunolabeling
was poor and restricted mostly to the stromal cells and, to a
lesser extent, to the surface and glandular epithelium. In the
group of cats receivingMPA, the TNF𝛼 immunostaining was
stronger than in cats in luteal phase.Themost distinct signals
were observed in the superficial and glandular epithelium
of the cats suffering from endometritis/pyometra complex.
In one immunohistochemical study on TNF𝛼 in the canine
endometrium during the course of the estrous cycle, positive
signals were found in the endometrial stroma and in both
superficial and glandular epithelium [40]. The intensity of
the stromal TNF𝛼 staining was the highest in anestrus and
proestrus dogs and diminished towards estrus and diestrus
[40]. Neither superficial nor glandular epithelium showed
statistical differences in TNF𝛼 immunoreactivity during the
canine estrous cycle and TNF𝛼 immunostaining remained
low to moderate in the course of the estrous cycle in dogs
[40]. In the present study TNF𝛼 immunoreaction seemed to
be similar in the surface and glandular epithelium in cats in
estrus and was scored as moderate to strong; however, TNF𝛼
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Figure 6: TNFR1 protein localization in endometria. Immunohistochemical (IHC) localization of TNFR1 in the endometria of cats collected
at (a) estrus phase (E, 𝑛 = 7) and (b) diestrus phase (D, 𝑛 = 8) from (c) cats that had been treated with a P
4
derivative analog,
medroxyprogesterone acetate (MPA, 𝑛 = 5); or (d) cats presenting the clinical symptoms of pyometra (PYO, 𝑛 = 3). (a) In females at estrus,
only weak TNFR1 signals are localized in the glandular and surface epithelium; (b) in females at diestrus, positive staining is localized in the
glandular and surface epithelium, similar to (c) MPA females; (d) in PYO females, strong signals are mostly localized in both the surface and
the glandular epithelium. Surface epithelium: white arrowheads; glandular epithelium: white arrows; endometrial stroma: black arrows.
protein immunostaining seemed to be much less distinct
in cats from diestrus. Immunostaining in the endometrial
stroma appeared unaffected by stage of the estrous cycle,
as similarly observed in the dog [40]. Immunolocalization
of TNF𝛼 receptors varied depending on the receptor type.
The most intense TNFR1 immunostaining was observed in
the surface and glandular epithelium, with similar intensity
in cats suffering from pyometra. Distinct TNFR1 immunos-
taining was also identified in animals receiving MPA espe-
cially in the surface and, to a lesser extent, in glandular
epithelia. These observations emphasized that in the uteri
of pyometric cats the pathological process affects mostly
the epithelial compartment of the endometrium, not the
stroma. Moderate or strong immunostaining for TNFR2 was
observed in the epithelia of queens receiving MPA as well
as those animals in estrus or diestrus, but it appeared less
strong than in inflamed uteri. No signals or poor staining
intensity was observed in the feline stroma for both receptors.
This observation is in agreement with a previous study in
cows, in which TNFR1 and TNFR2 proteins were weakly
expressed in the stroma [41]. The sources of endometrial
TNF𝛼 were the superficial and glandular epithelial cells
and the endothelial lining of blood vessels located in the
bovine endometrium [41]. That study showed significantly
higher expression of TNF𝛼 in the luteal and follicular
endometrium [41], suggesting its regulation by sex steroids. A
similar result, with regard to the spatial localization of TNF𝛼
and TNFR1 protein, was obtained for equine endometrium;
however, intensity of immunostaining was not affected by
the phase of the estrous cycle [31]. Observations made in
cows partially agreed with the present observation that the
source of TNF𝛼 was the epithelium, not the stroma, at least
in follicular endometrium [41]. In the present study, TNF𝛼
seemed to be more weakly expressed in the luteal phase
endometrium compared with follicular phase endometrium,
which is not exactly identical with our previous observations
made with whole uterine fragments. In that study, uterine
TNF𝛼 protein expression and mRNA transcription did not
differ between cats in the follicular or luteal phases [19].
This discrepancy may be due to different methods used
for TNF𝛼 analysis. Furthermore, the overriding goal of the
present study was to measure semiquantitatively TNF𝛼 and
its receptors in endometrium that was inflamed or exposed to
exogenous P
4
and to compare these observationswith protein
immunoreactivity in the follicular or luteal phases. The
present observations confirmed that the TNF𝛼/TNFRs com-
plex is overexpressed in the inflammatory uterus and may be
involved in the development of the changes in the endome-
trial glands of cats receiving exogenous P
4
as a hormonal
contraceptive.
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Figure 7: TNFR2 protein localization in endometria. Immunohistochemical (IHC) localization of TNFR2 in the endometria of cats collected
at (a) estrus phase (E, 𝑛 = 7) and (b) diestrus phase (D, 𝑛 = 8) from (c) cats that had been treated with a P
4
derivative analog,
medroxyprogesterone acetate (MPA, 𝑛 = 5); or (d) cats presenting the clinical symptoms of pyometra (PYO; 𝑛 = 3). In females at (a)
estrus and (b) diestrus, TNFR2 expression is localized in the glandular and surface epithelium; (c) in MPA females, very strong signals are
observed in the endometrial glands, whereas (d) in PYO females, strong signals are present in surface and glandular epithelium and weaker
ones in endometrial stroma. Surface epithelium: white arrowheads; glandular epithelium: white arrows; endometrial stroma: black arrows.
Figure 8: Isotype control with a nonimmunized rabbit serum at
a dilution of 1 : 25. No positive signals are observed in the feline
endometrium.
In summary, this study shows that feline epithelial
endometrial cells produce TNF𝛼 as a result of LPS stim-
ulation, which emphasizes the defensive role of epithelial
cells during infections with Gram-negative bacteria. Tumor
necrosis factor 𝛼-augmented PG secretion is abolished
by PLA
2
and COX-2 and, partially, by MAPK inhibitors.
Changes in TNF𝛼/TNFR1 and 2 expression were discernable
in the uteri of cats receiving octane medroxyprogesterone
compared with those of estrus and diestrus queens, so this
medication may favor the development of endometritis and
pyometra in cats.
Conflict of Interests
The authors declare that there is no conflict of interests
regarding the publication of this paper.
Authors’ Contribution
Ewelina Jursza carried out cell cultures and immunohisto-
chemical studies. Anna Z. Szo´stek participated in immunoas-
say procedures. Mariusz P. Kowalewski participated in
immunohistochemical studies and helped in drafting of the
paper. Alois Boos andKiyoshiOkuda helped in the drafting of
the paper. Marta J. Siemieniuch conceived and designed the
study, performed hormonal analysis, and drafted the paper.
All authors read and approved the final paper.
Acknowledgments
This study was supported by Grants-in-Aid for Scientific
Research from the Polish Ministry of Scientific Research and
Mediators of Inflammation 11
0
20
40
60
80
100
E D
M
PA
PY
O E D
M
PA
PY
O E D
M
PA
PY
O
(%
)
Surface
epithelium
Glandular
epithelium
Endometrial
stroma
TNF𝛼 intensity scores
(a)
0
20
40
60
80
100
E D
M
PA
PY
O E D
M
PA
PY
O E D
M
PA
PY
O
(%
)
Surface
epithelium
Glandular
epithelium
Endometrial
stroma
TNFR1 intensity scores
(b)
3
2
1
0
Intensity scores 
0
20
40
60
80
100
E D
M
PA
PY
O E D
M
PA
PY
O E D
M
PA
PY
O
(%
)
Surface
epithelium
Glandular
epithelium
Endometrial
stroma
TNFR2 staining scores
(c)
Figure 9: Graphic illustration of the relative intensity scores for
TNF𝛼, TNFR1, and TNFR2 in different compartments of the endo-
metria of cats collected at estrus (E, 𝑛 = 7) and diestrus (D, 𝑛 =
8) from cats that had been treated with a P
4
derivative analog,
medroxyprogesterone acetate (MPA, 𝑛 = 5), or cats presenting the
clinical symptoms of pyometra (PYO, 𝑛 = 3).
High Education (NN308560740). Ewelina Jursza was sup-
ported by the European Union through the European Social
Fund. Authors are indebted to the staff of the Department of
Animal Reproduction with Clinic, the Faculty of Veterinary
Medicine, University of Warmia and Mazury in Olsztyn, and
DOGMED Veterinary Clinic from Olsztyn for allowing the
tissue collection.
References
[1] J. O. Joshua, “Some conditions seen in feline practice attrib-
utable to hormonal causes,” Veterinary Record, vol. 88, no. 20,
pp. 511–514, 1971.
[2] S. J. Roberts, “Infertility and reproductive diseases in bitches
and queens,” in Veterinary Obstetrics and Genital Diseases, V.
T. Woodstock and S. J. Roberts, Eds., pp. 709–751, 3rd edition,
1986.
[3] G. K. Dhaliwal, G. C. W. England, and D. E. Noakes, “The
influence of exogenous steroid hormones on steroid receptors,
uterine histological structure and the bacterial flora of the
normal bitch,”Animal Reproduction Science, vol. 56, no. 3-4, pp.
259–277, 1999.
[4] D. E. Noakes, G. K. Dhaliwal, and G. C. England, “Cystic endo-
metrial hyperplasia/pyometra in dogs: a review of the causes
and pathogenesis,” Journal of Reproduction and Fertility, vol. 57,
pp. 395–406, 2001.
[5] S.D. Johnston,M.V. RootKoostritz, andP.N.Olson, “Disorders
of the feline uterus and uterine tubes (oviducts),” in Canine and
Feline Theriogenology, pp. 463–470, W.B. Saunders, Philadel-
phia, Pa, USA, 2001.
[6] C. Dow, “Experimental uterine infection in the domestic cat,”
Journal of Comparative Pathology and Therapeutics, vol. 72, pp.
303–307, 1962.
[7] K. J. Kenney, D. T. Matthiesen, N. O. Brown, and R. L. Brad-
ley, “Pyometra in cats: 183 cases (1979–1984),” Journal of the
American Veterinary Medical Association, vol. 191, no. 9, pp.
1130–1132, 1987.
[8] D. F. Lawler, R. H. Evans, T. J. Reimers, E. D. Colby, and K.
L. Monti, “Histopathologic features, environmental factors, and
serum estrogen, progesterone, and prolactin values associated
with ovarian phase and inflammatory uterine disease in cats,”
American Journal of Veterinary Research, vol. 52, no. 10, pp.
1747–1753, 1991.
[9] D. F. Lawler, S. D. Johnston, R. L. Hegstad, D. G. Keltner, and S.
F. Owens, “Ovulation without cervical stimulation in domestic
cats,” Journal of Reproduction and Fertility, vol. 47, pp. 57–61,
1993.
[10] S. R. Paape, V. M. Shille, H. Seto, and G. H. Stabenfeldt, “Luteal
activity in the pseudopregnant cat,”Biology of Reproduction, vol.
13, no. 4, pp. 470–474, 1975.
[11] V. M. Shille and G. H. Stabenfeldt, “Luteal function in the
domestic cat during pseudopregnancy and after treatment with
prostaglandin F2𝛼,” Biology of Reproduction, vol. 21, no. 5, pp.
1217–1223, 1979.
[12] D. B. Wilkins, “Pyometritis in a spayed cat,” Veterinary Record,
vol. 91, no. 1, p. 24, 1972.
[13] M. Siemieniuch, T. Fronczek,M. Błaszkowska,W. Bielas, and A.
Dubiel, “Bacterial flora of the genital-urinary tract in clinically
healthy queens,” Medycyna Weterynaryjna, vol. 61, no. 11, pp.
1305–1307, 2005.
[14] L. L. Clemetson and A. C. Ward, “Bacterial flora of the vagina
and uterus of healthy cats,” Journal of the American Veterinary
Medical Association, vol. 196, no. 6, pp. 902–906, 1990.
[15] O. Takeuchi and S. Akira, “Pattern recognition receptors and
inflammation,” Cell, vol. 140, no. 6, pp. 805–820, 2010.
[16] I. M. Sheldon and H. Dobson, “Postpartum uterine health in
cattle,” Animal Reproduction Science, vol. 82-83, pp. 295–306,
2004.
[17] G. Vince, S. Shorter, P. Starkey et al., “Localization of tumour
necrosis factor production in cells at thematerno/fetal interface
12 Mediators of Inflammation
in human pregnancy,” Clinical and Experimental Immunology,
vol. 88, no. 1, pp. 174–180, 1992.
[18] J. S.Hunt,H. Chen, X.Hu, T. Chen, andD.C.Morrison, “Tumor
necrosis factor-𝛼 gene expression in the tissues of normalmice,”
Cytokine, vol. 4, no. 5, pp. 340–346, 1992.
[19] M. J. Siemieniuch, K. Ogrodowska, H. Ohgawara, D. J. Skarzyn-
ski, and K. Okuda, “Tumor Necrosis Factor-alpha as a possible
auto-/paracrine factor affecting estrous cycle in the cat uterus,”
Polish Journal of Veterinary Sciences, vol. 13, no. 4, pp. 605–613,
2010.
[20] C. M. Otto and C. A. Rawlings, “Tumor necrosis factor produc-
tion in cats in response to lipopolysaccharide: an in vivo and in
vitro study,”Veterinary Immunology and Immunopathology, vol.
49, no. 1-2, pp. 183–188, 1995.
[21] M. J. Siemieniuch, A. Bowolaksono, D. J. Skarzynski, and K.
Okuda, “Ovarian steroids regulate prostaglandin secretion in
the feline endometrium,”Animal Reproduction Science, vol. 120,
no. 1–4, pp. 142–150, 2010.
[22] J. R.Malayer andV.M.Woods, “Expression of estrogen receptor
and maintenance of hormone-responsive phenotype in bovine
fetal uterine cells,” Domestic Animal Endocrinology, vol. 15, no.
3, pp. 141–154, 1998.
[23] C. Labarca and K. Paigen, “A simple, rapid, and sensitive DNA
assay procedure,” Analytical Biochemistry, vol. 102, no. 2, pp.
344–352, 1980.
[24] M. J. Siemieniuch, E. Jursza, A. Z. Szostek, D. J. Skarzynski,
A. Boos, and M. P. Kowalewski, “Steroidogenic capacity of
the placenta as a supplemental source of progesterone dur-
ing pregnancy in domestic cats,” Reproductive Biology and
Endocrinology, vol. 10, p. 89, 2012.
[25] S. Herath, D. P. Fischer, D. Werling et al., “Expression and
function of toll-like receptor 4 in the endometrial cells of the
uterus,” Endocrinology, vol. 147, no. 1, pp. 562–570, 2006.
[26] I. M. Sheldon andM. H. Roberts, “Toll-like receptor 4 mediates
the response of epithelial and stromal cells to lipopolysaccha-
ride in the endometrium,” PLoS ONE, vol. 5, no. 9, Article ID
e12906, pp. 1–10, 2010.
[27] C. C. Czerkinsky, L. Nilsson, H. Nygren, O¨. Ouchterlony, and
A. Tarkowski, “A solid-phase enzyme-linked immunospot
(ELISPOT) assay for enumeration of specific antibody-
secreting cells,” Journal of Immunological Methods, vol. 65, no.
1-2, pp. 109–121, 1983.
[28] M. L. Turner, G. D. Healey, and I. M. Sheldon, “Immunity and
inflammation in the uterus,” Reproduction in Domestic Animals,
vol. 47, supplement 4, pp. 402–409, 2012.
[29] Y.Miyamoto, D. J. Skarzynski, andK.Okuda, “Is tumor necrosis
factor a trigger for the initiation of endometrial prostaglandin
F(2𝛼) release at luteolysis in cattle?” Biology of Reproduction,
vol. 62, no. 5, pp. 1109–1115, 2000.
[30] A. Blitek and A. J. Ziecik, “Role of tumour necrosis factor 𝛼 in
stimulation of prostaglandins F2𝛼 and E2 release by cultured
porcine endometrial cells,” Reproduction in Domestic Animals,
vol. 41, no. 6, pp. 562–567, 2006.
[31] A. Galva˜o, L. Valente, D. J. Skarzynski et al., “Effect of cytokines
and ovarian steroids on equine endometrial function: an in vitro
study,” Reproduction, Fertility and Development, vol. 25, no. 7,
pp. 985–997, 2013.
[32] D. B. Chen, Z. M. Yang, R. Hilsenrath, S.-P. Le, and M.
J. K. Harper, “Stimulation of prostaglandin (PG) F(2𝛼) and
PGE2 release by tumour necrosis factor-𝛼 and interleukin-
1𝛼 in cultured human luteal phase endometrial cells,” Human
Reproduction, vol. 10, no. 10, pp. 2773–2780, 1995.
[33] N. L. Poyser, “The control of prostaglandin production by the
endometrium in relation to luteolysis and menstruation,” Pro-
staglandins Leukotrienes and Essential Fatty Acids, vol. 53, no. 3,
pp. 147–195, 1995.
[34] M. A. Clark, M.-J. Chen, S. T. Crooke, and J. S. Bomalaski,
“Tumor necrosis factor (cachectin) induces phospholipase A
2
activity and synthesis of a phospholipase A
2
-activating protein
in endothelial cells,”Biochemical Journal, vol. 250, no. 1, pp. 125–
132, 1988.
[35] D. J. Skarzynski, Y. Miyamoto, and K. Okuda, “Production of
prostaglandin F(2𝛼) by cultured bovine endometrial cells in
response to tumor necrosis factor 𝛼: cell type specificity and
intracellular mechanisms,” Biology of Reproduction, vol. 62, no.
5, pp. 1116–1120, 2000.
[36] T. A. Sato, J. A. Keelan, M. Blumenstein, and M. D. Mitchell,
“Efficacy and specificity of non-steroidal anti-inflammatory
drugs for the inhibition of cytokine-stimulated prostaglandin
E2 secretion by amnion-derived WISH cells,” Prostaglandins
Leukotrienes and Essential Fatty Acids, vol. 66, no. 5-6, pp. 525–
527, 2002.
[37] G. Chen and D. V. Goeddel, “TNF-R1 signaling: a beautiful
pathway,” Science, vol. 296, no. 5573, pp. 1634–1635, 2002.
[38] G. N. Rao, A. S. Baas, W. C. Glasgow, T. E. Eling, M. S. Runge,
and R. W. Alexander, “Activation of mitogen-activated protein
kinases by arachidonic acid and its metabolites in vascular
smooth muscle cells,” Journal of Biological Chemistry, vol. 269,
no. 51, pp. 32586–32591, 1994.
[39] R. Sakumoto, S. Murakami, and K. Okuda, “Tumor necrosis
factor-alpha stimulates prostaglandin F2alpha secretion by
bovine luteal cells via activation of mitogen-activated protein
kinase and phospholipase A
2
pathways,” Molecular Reproduc-
tion and Development, vol. 56, no. 3, pp. 387–391, 2000.
[40] R. Payan-Carreira, M. A. Pires, B. Stro¨m Holst, and H.
Rodriguez-Martinez, “Tumour necrosis factor in the canine
endometrium: an immunohistochemical study,” Reproduction
in Domestic Animals, vol. 46, no. 3, pp. 410–418, 2011.
[41] K. Okuda, R. Sakumoto, N. Okamoto et al., “Cellular localiza-
tion of genes and proteins for tumor necrosis factor-𝛼 (TNF),
TNF receptor types I and II in bovine endometrium,”Molecular
and Cellular Endocrinology, vol. 330, no. 1-2, pp. 41–48, 2010.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
